Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06666751 · ClinicalTrials.gov registry record

Anterior Segment Optical Coherence Tomography Microstent Positioning

A clinical trial of Glaucoma and Intraocular Pressure, sponsored by University of Utah.

Active
Registry status
116
Enrollment target
1
Study location

NCT06666751: Active study of Glaucoma and Intraocular Pressure, sponsored by University of Utah.

NCT06666751 is a study of Glaucoma and Intraocular Pressure that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 116 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06666751, a study of Glaucoma and Intraocular Pressure, is active but no longer recruiting, sponsored by University of Utah.

ACTIVE NOT RECRUITING
Registry status
116 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to learn about the long-term results of glaucoma stent surgery in men and women 18 or older who have had cataract and microstent surgery in the past 2 years at the Moran Eye Center. The main questions the study aims to answer are: 1. How often are microstents mispositioned? 2. What effect does microstent positioning have on intraocular pressure after surgery? Participants will have a one-time clinic visit for an eye exam and Optical Coherence Tomography (OCT) . From the eye exam and OCT, Researchers will assess and categorize the position of the microstents and assess the Schlemm's canal dilation. Researchers will review the participants' medical records to acquire 2-year data for the following: 1. Surgeon type and level of experience (resident, fellow, attending ophthalmologist) 2. Proportions of proper gonioscopic placement intraoperatively for each surgeon group 3. Effectiveness of surgery, based on change in intraocular pressure (IOP) from baseline medicated IOP, number of IOP-lowering medications the patient was able to discontinue, and rate of need for additional glaucoma surgery.

Primary Outcome

Positioning of each participant's stent(s) will be evaluated by anterior segment OCT at the one-time clinical study visit. iStent Inject W mispositions are defined as: microstent protrusion (entire conical head not within canal), stent completely buried in the trabeculae, or not seen (i.e. 0 or only 1 stent). If the iStent position is located but the examiner is unsure if it is positioned correctly, it will be counted as misposition. If the iStent is not seen, an in office gonioscopy will be pe

Conditions Studied

Glaucoma Intraocular Pressure Stent Migration Stent Dislodgement

Interventions

  • PROCEDURE Cataract plus Microstent surgery

Study Locations (1)

Utah

  • Moran Eye Center - Murray

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2024-04-09
Est. Completion 2027-05-30
University of Utah

818 total trials

What the registry record for NCT06666751 still lists

NCT06666751 is an observational study that tracks outcomes without assigning an intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (87% lower).

The record links to 4 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Cataract plus Microstent surgery is the first listed.

NCT06666751 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT06666751 about?

NCT06666751 is a clinical study titled "Anterior Segment Optical Coherence Tomography Microstent Positioning". The goal of this observational study is to learn about the long-term results of glaucoma stent surgery in men and women 18 or older who have had cataract and microstent surgery in the past 2 years at the Moran Eye Center. The main questions the study aims to answer are: 1. How often are microstents...

What is the current status of trial NCT06666751?

This trial is currently active not recruiting. The enrollment target is 116 participants. The study started on 2024-04-09. Estimated completion is 2027-05-30.

What conditions does trial NCT06666751 study?

This clinical trial studies the following conditions: Glaucoma, Intraocular Pressure, Stent Migration, Stent Dislodgement.

What interventions are being tested in trial NCT06666751?

The interventions under investigation include: Cataract plus Microstent surgery (PROCEDURE).

Who is sponsoring clinical trial NCT06666751?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06666751 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06666751's enrollment target sits among peer trials

116 41st of 92 higher than 52 of 92 other Glaucoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03014687 · 116 participants · Phase 4

    Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

  • NCT03214562 · 116 participants · Phase 1

    Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

  • NCT03847467 · 116 participants · Phase 1

    Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  • NCT04222413 · 116 participants · Phase 1

    Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06666751, the US trial registry maintained by the National Library of Medicine. NCT06666751 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.